Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer

Joachim B Schnier1, Kayoko Nishi, Paul H Gumerlock

  • 1Department of Biochemistry and Molecular Medicine, University of California, One Shields Avenue, Davis, CA 95616, USA. jbschnier@ucdavis.edu

BMC Urology
|March 26, 2005
PubMed
Abstract

Insights

Androgen signaling increases prostate cancer cell glycogen. Inhibiting glycogen breakdown with CP-91149 enhances this effect, reducing cell survival and recurrence risk.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Androgen withdrawal in prostate cancer reduces glucose metabolism.
  • Glycogen metabolism's role in androgen response is unstudied.

Purpose of the Study:

  • Investigate androgen's effects on glycogen metabolism in prostate cancer cells.
  • Determine if targeting glycogen metabolism impacts androgen response.

Main Methods:

  • Utilized androgen receptor (AR)-reconstituted PC3 and LNCaP cell lines.
  • Measured glycogen phosphorylase (GP) and glycogen synthase (GS) activity.
  • Assessed glycogen content and cell number following androgen treatment and GP inhibition.

Main Results:

  • Androgen increased glycogen content 2-5 fold in PC3 cells, accompanied by G1 arrest and cell reduction.
  • Androgen elevated Glucose-6-P, GS, and GP activity.
  • GP inhibition (CP-91149) enhanced glycogen accumulation and reduced cell number in both cell lines.

Conclusions:

  • Increased glycogenesis is an androgen receptor-mediated response.
  • Blocking glycogenolysis via GP inhibition potentiates androgen's anti-proliferative effect.
  • Combined GP inhibition and hormone therapy may improve prostate cancer treatment efficacy.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...